300683 海特生物
按盤價 
27.080 +2.270 (+9.150%)
27.080 +2.270 (+9.150%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.670 | -5.046 | -0.605 | 1.371 | -1.450 |
| 總資產報酬率 ROA (%) | -0.557 | -4.256 | -0.519 | 1.132 | -1.149 |
| 投入資產回報率 ROIC (%) | -0.609 | -4.602 | -0.554 | 1.211 | -1.248 | 邊際利潤分析 |
| 銷售毛利率 (%) | 39.910 | 42.709 | 48.465 | 56.922 | 59.154 |
| 營業利潤率 (%) | -21.147 | -23.755 | -0.991 | 3.472 | -6.692 |
| 息稅前利潤/營業總收入 (%) | -21.752 | -26.421 | -2.769 | 1.288 | -10.913 |
| 淨利潤/營業總收入 (%) | -13.263 | -21.293 | -1.147 | 4.883 | -4.899 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 188.797 | 73.686 | 33.176 | 62.355 | 6.107 |
| 價值變動淨收益/利潤總額(%) | -21.257 | -11.570 | -303.115 | 68.468 | -33.814 |
| 營業外收支淨額/利潤總額(%) | 1.953 | 5.864 | 12.800 | -4.321 | 6.135 | 償債能力分析 |
| 流動比率 (X) | 4.728 | 4.299 | 5.072 | 6.349 | 3.616 |
| 速動比率 (X) | 4.346 | 3.960 | 4.650 | 6.062 | 3.427 |
| 資產負債率 (%) | 16.431 | 16.011 | 13.732 | 13.140 | 21.112 |
| 帶息債務/全部投入資本 (%) | 3.434 | 5.182 | 6.808 | 6.115 | -- |
| 股東權益/帶息債務 (%) | 2,646.729 | 1,756.515 | 1,342.007 | 1,498.597 | 755.296 |
| 股東權益/負債合計 (%) | 505.228 | 520.916 | 621.573 | 655.765 | 370.143 |
| 利息保障倍數 (X) | 118.774 | 22.283 | 1.696 | -0.631 | 2.885 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 35.200 | 34.293 | 41.732 | 62.172 | 0.000 |
| 存貨周轉天數 (天) | 134.235 | 123.943 | 97.300 | 96.042 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 14/05/2024 10:17 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
